Common Reasons Medical and Scientific Manuscripts Get Desk-Rejected

Clinical and biomedical journals reject a substantial share of submissions before peer review even begins. For researchers working in health sciences, understanding why medical papers get desk rejected is not just useful, it's essential preparation for every submission you make.

Publishing outside medicine? See our broader guide to handling a desk rejection from any Scopus-indexed journal, including a full step-by-step resubmission plan.

Unlike rejections that follow peer review, a desk rejection carries no reviewer commentary, no scored critique, and often only a short, formulaic explanation. This leaves many authors, particularly international graduate students and early-career clinicians, unsure of what actually went wrong. This article breaks down the specific, recurring scientific manuscript rejection reasons that editors cite most often in medical and clinical journals, so you can identify and correct these issues before submission rather than after.

Why editorial screening is so strict in medical journals

Medical and clinical journals face a particular set of pressures that make their desk-rejection rates higher than in many other fields. First, patient safety and clinical relevance mean editors must screen for methodological rigor immediately, since flawed studies that reach publication can influence real-world clinical decisions. Second, high-impact medical journals receive enormous submission volumes, often several thousand manuscripts per year, against a fixed number of publication slots. Third, regulatory and ethical requirements, such as trial registration and informed consent documentation, are non-negotiable checkpoints that many other fields do not require at the same level of scrutiny.

Together, these pressures mean editors are trained to spot disqualifying issues within minutes. Below are the reasons that appear most consistently across editorial rejection letters.

1. Missing or incomplete ethical approval documentation

This is one of the fastest paths to a desk rejection in medical research. Journals require a clear statement confirming institutional review board (IRB) or ethics committee approval, along with the approval number and the name of the approving body. Manuscripts that omit this information, provide it vaguely, or describe approval that appears to postdate data collection are frequently rejected without further review.

For clinical trials specifically, missing or incorrect trial registration numbers (such as those from ClinicalTrials.gov or the ISRCTN registry) are an equally common trigger. Many journals now cross-check registration details before a manuscript is even assigned to an editor.

2. Reporting guideline non-compliance

A frequent reason for a clinical trial paper desk rejection is failure to follow the correct reporting guideline for the study design. Editors expect the manuscript to align with the relevant checklist: CONSORT for randomized controlled trials, STROBE for observational studies, PRISMA for systematic reviews and meta-analyses, and STARD for diagnostic accuracy studies.

Submitting a randomized trial manuscript without a completed CONSORT checklist and flow diagram signals to editors that the study may not conform to current reporting standards, regardless of the quality of the underlying data. Many journals now require these checklists as a mandatory upload at submission, and an incomplete or missing checklist can lead to an automatic desk rejection before the editor has read the full text.

3. Sample size and statistical power concerns

Underpowered studies are a recurring concern in clinical and biomedical submissions. If a manuscript does not include a sample size justification or power calculation, and the study appears too small to detect a clinically meaningful effect, editors may reject it outright rather than risk publishing an inconclusive or misleading result.

This is particularly common in pilot studies or single-center trials that do not clearly frame themselves as exploratory or hypothesis-generating work. Framing matters here: a small study presented honestly as preliminary can be publishable in the right venue, while the same study presented as a definitive clinical finding is far more likely to be rejected.

4. Scope and audience mismatch

As with other scientific fields, scope mismatch remains one of the most common reasons any manuscript gets desk rejected, and medical journals are no exception. A manuscript focused on a narrow subspecialty topic submitted to a general medicine journal, or a basic science paper submitted to a purely clinical journal, will often be rejected regardless of quality.

Before submitting, review the journal's aims and scope statement carefully, and examine several recent issues to confirm that your study's population, intervention, and outcome measures align with what that journal actually publishes.

5. Weak or unclear clinical significance

Editors at medical journals are trained to ask a specific question early in their review: does this finding change clinical practice, understanding, or future research direction? A manuscript that reports statistically significant results without articulating clinical significance, meaning the real-world magnitude and relevance of the effect, is vulnerable to desk rejection. This is especially true when a paper reports a statistically significant but clinically marginal effect size without discussing whether that difference matters to patients or practitioners.

6. Concerns about duplicate or redundant publication

Medical journals maintain strict policies against duplicate publication, defined as submitting substantially the same data, analysis, or conclusions that have already appeared elsewhere, including conference proceedings, preprints, or previously published journal articles. Editors routinely run plagiarism and text-overlap screening as part of the desk-review process. Even unintentional overlap, such as reusing a large portion of a previously published methods section, can trigger rejection or require formal clarification before the manuscript proceeds.

7. Poor structuring of the abstract

In medical journals, the abstract is often the only section an editor reads in full before making an initial screening decision. A structured abstract that fails to follow the required format (typically Background, Methods, Results, Conclusions) or that omits key numerical findings in favor of vague summary statements is a common and avoidable trigger for rejection. Editors specifically look for abstracts that state the sample size, primary outcome measure, and effect size or p-value, since these details allow a rapid assessment of whether the study is substantial enough to warrant full review.

8. Poor statistical reporting or errors in methodology

Beyond sample size, editors and their statistical screeners look for specific methodological red flags, including the use of statistical tests inappropriate for the data type or distribution, missing information on how missing data were handled, absence of confidence intervals alongside p-values, and unclear description of primary versus secondary outcomes defined after data collection had already begun. Any of these can prompt an editor to conclude that the manuscript needs substantial statistical revision before it is ready for peer review, resulting in a desk rejection rather than a request for revision.

9. Overstated conclusions relative to the data

Medical journal editors are particularly attentive to conclusions that outpace the evidence presented. Common examples include recommending changes to clinical practice based on a single small study, generalizing findings from a narrow population to a broader one without qualification, or using causal language to describe results from an observational design. This concern is amplified in health sciences because overstated conclusions carry real downstream risk if they influence clinical decision-making or public health messaging.

10. Language, clarity, and formatting issues

For international researchers publishing in English-language journals, language clarity remains a frequent, if less discussed, contributor to desk rejection. Awkward phrasing, inconsistent terminology for the same clinical concept, and unclear sentence structure can all obscure a study's genuine contribution and lead an editor to reject a manuscript that might otherwise have been sound.

Formatting non-compliance, including incorrect reference styles, exceeding word limits, or missing required sections such as conflict-of-interest and funding statements, compounds this problem. Editors managing large submission volumes are unlikely to spend time correcting these issues themselves. They simply reject and move to the next manuscript in the queue.

A practical pre-submission checklist

Before submitting to any medical or scientific journal, confirm the following: ethics approval and, where applicable, trial registration details are included and accurate; the correct reporting guideline checklist (CONSORT, STROBE, PRISMA, STARD, or equivalent) is completed and attached; sample size justification or power calculation is present and appropriately framed; the manuscript's scope clearly matches the target journal's stated aims and recent publication history; clinical significance, not just statistical significance, is explicitly discussed; the abstract is structured correctly and includes key numerical findings; statistical methods are appropriate for the data and clearly reported, including confidence intervals; conclusions are proportionate to the strength and generalizability of the evidence; language has been reviewed for clarity, particularly by a second reader if English is not your first language; and formatting fully complies with the target journal's author guidelines.

Prevention is more efficient than recovery

Every one of these issues is identifiable and correctable before submission. The researchers who publish consistently in competitive medical journals are rarely those who write flawless first drafts. They are the ones who systematically check their manuscript against these known failure points before it ever reaches an editor's desk.

A desk rejection costs you time you cannot get back: weeks or months before you can resubmit elsewhere, while your data ages and your competitive window narrows. Treating pre-submission review as a mandatory step, not an optional one, is the single most effective way to avoid editorial rejection.